Results of using the drug price negotiation process in the drug selection process of Kalasin Hospital.

Abstract

     This study of the drug price negotiation process during the drug selection process for inclusion in the Kalasin Hospital drug list had the following objectives: 1. To reduce the cost of new drug procurement at Kalasin Hospital; 2. To compare the value of new drug procurement before and after the price negotiation process was added; and 3. To develop an effective drug price negotiation approach. The study selected drugs for inclusion in the new hospital drug list for fiscal year 2024, from April 1, 2024, to January 31, 2025. This quasi-experimental research compared the value of new drug procurement before and after the price negotiation process was added. Descriptive statistics, including frequency and percentage, were used, as well as inferential statistics, including the independent t-test and content analysis.

     The research results revealed that of the 33 new drugs proposed for inclusion in the hospital drug list, 28 of them were successfully discounted, representing 84.85%. The procurement cost before negotiation was 8,784,375.79 baht, the procurement cost after negotiation was 7,890,581.71 baht, and the savings were 893,794.08 baht (a 10.18% reduction). This difference was statistically significant (p = 0.002). Qualitative analysis revealed effective negotiation strategies: 1. Preparation of reference price data, 2. Displaying order quantities, 3. Building long-term relationships, 4. Negotiating options, and 5. Drug types.